The company's balance sheet can handle adversity, but its ea...
The company's balance sheet can handle adversity, but its earnings loss, negative free cash outflow of CN¥1.6b, and accounting loss of CN¥372m raise concerns about financial stability. It may need to raise more capital if it doesn't reach break-even soon.
Is Zhejiang Orient Gene BiotechLtd (SHSE:688298) Using Debt Sensibly?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment